alan clucas

head of project leadership

About

Head of Development, Galderma Global Prescription Business Unit at Galderma

Country

france

City

france

Industry

pharmaceuticals

Skill

clinical development, clinical research, clinical trials, pharmaceutical industry, drug development, regulatory submissions, gcp, cro, biotechnology, ctms, life sciences, medical affairs, dermatology, regulatory affairs, translational medicine, drug discovery, oncology, therapeutic areas, pharmacovigilance

Experience

head clinical development

galderma

1994-1 - 2000-1 · 6 yrs 1 mo

head of project leadership

galderma

2017-1 - Present · 9 yrs 9 mos

vice-president, head of clinical sciences

pfizer

2009-1 - 2015-4 · 6 yrs 4 mos

dermatology ta head

pfizer

2005-7 - 2009-1 · 3 yrs 7 mos

clinical exploratory head

pfizer

2000-10 - 2005-7 · 4 yrs 10 mos

worldwide project leader, transdermals

rhone-poulenc rorer

1992-1 - 1994-1 · 2 yrs 1 mo

senior project leader

galderma

2015-4 - 2015-10 · 7 mos

head of development, global prescription business unit

galderma

2015-10 - 2016-12 · 1 yr 3 mos

A global company exclusively dedicated to dermatologyDating back to 1961, Galderma is now present in 80 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails. Strategic brands include Epiduo, Oracea, Differin, Mirvaso, Soolantra, Tri-Luma, Loceryl, Benzac, Cetaphil, Excipial, Daylong, Metvix, Azzalure/Dysport, Restylane and Emervel.For more information, please visit www.galderma.com